Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA … – Economic Times

Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA
Economic Times
NEW DELHI: Indian drug makers, including Aurobindo and Glenmark, are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and allergies in the US market. Last week the US Food and Drug

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.